These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 17055825)
1. Repetitive oocyte donation. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2006 Nov; 86(5 Suppl 1):S216-7. PubMed ID: 17055825 [No Abstract] [Full Text] [Related]
2. Repetitive oocyte donation. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2004 Sep; 82 Suppl 1():S158-9. PubMed ID: 15363716 [No Abstract] [Full Text] [Related]
3. The incidence of both serious and minor complications in young women undergoing oocyte donation. Maxwell KN; Cholst IN; Rosenwaks Z Fertil Steril; 2008 Dec; 90(6):2165-71. PubMed ID: 18249368 [TBL] [Abstract][Full Text] [Related]
4. Egg-stracting answers. Kiser K Minn Med; 2007 May; 90(5):16-7. PubMed ID: 17550080 [No Abstract] [Full Text] [Related]
5. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Hernández ER; Gómez-Palomares JL; Ricciarelli E Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236 [TBL] [Abstract][Full Text] [Related]
6. Repetitive oocyte donation. Practice Committee of American Society for Reproductive Medicine Fertil Steril; 2008 Nov; 90(5 Suppl):S194-5. PubMed ID: 19007628 [TBL] [Abstract][Full Text] [Related]
8. Health effects of egg donation may take decades to emerge. Pearson H Nature; 2006 Aug; 442(7103):607-8. PubMed ID: 16900163 [No Abstract] [Full Text] [Related]
9. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. Sauer MV Am J Obstet Gynecol; 2001 Feb; 184(3):277-8. PubMed ID: 11228473 [TBL] [Abstract][Full Text] [Related]
10. Assessing the risk of ovarian hyperstimulation syndrome in egg donation: implications for human embryonic stem cell research. Ellison B; Meliker J Am J Bioeth; 2011 Sep; 11(9):22-30. PubMed ID: 21877969 [TBL] [Abstract][Full Text] [Related]
11. Reconsidering risk to women: oocyte donation for human embryonic stem cell research. Bamford R Am J Bioeth; 2011 Sep; 11(9):37-9. PubMed ID: 21877973 [No Abstract] [Full Text] [Related]
12. The conundrum of oocyte donation, human research, OHSS, and ethics. Stein AL Am J Bioeth; 2011 Sep; 11(9):35-7. PubMed ID: 21877972 [No Abstract] [Full Text] [Related]
14. A precautionary approach to oocyte donation for stem cell nuclear transplantation. Kalfoglou AL; Sauer MV Am J Bioeth; 2011 Sep; 11(9):31-3. PubMed ID: 21877970 [No Abstract] [Full Text] [Related]
15. Ovulation induction treatment and risk of borderline ovarian tumors. Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767 [TBL] [Abstract][Full Text] [Related]
16. Harmony and compensation for oocyte providers. Batzer F; Daar J Am J Bioeth; 2011 Sep; 11(9):39-41. PubMed ID: 21877974 [No Abstract] [Full Text] [Related]
17. A case of severe ovarian hyperstimulation in a healthy oocyte donor. Halme J; Toma SK; Talbert LM Fertil Steril; 1995 Oct; 64(4):857-9. PubMed ID: 7672162 [TBL] [Abstract][Full Text] [Related]
18. Oocytes for research: reevaluating risks and compensation. Fiore RN; Hinsch KM Am J Bioeth; 2011 Sep; 11(9):42-3. PubMed ID: 21877975 [No Abstract] [Full Text] [Related]
19. Considering the risks to economically disadvantaged egg donors. Kalbian A Am J Bioeth; 2011 Sep; 11(9):44-5. PubMed ID: 21877976 [No Abstract] [Full Text] [Related]